SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999371-24-010281
Filing Date
2024-08-16
Accepted
2024-08-16 17:18:38
Documents
95
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_063024.htm   iXBRL 10-Q 1509747
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 16003
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 16241
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 6087
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-02.htm EX-32.02 6304
  Complete submission text file 0001999371-24-010281.txt   8505181

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnxp-20240630.xsd EX-101.SCH 66584
7 XBRL CALCULATION FILE tnxp-20240630_cal.xml EX-101.CAL 78620
8 XBRL DEFINITION FILE tnxp-20240630_def.xml EX-101.DEF 289516
9 XBRL LABEL FILE tnxp-20240630_lab.xml EX-101.LAB 521295
10 XBRL PRESENTATION FILE tnxp-20240630_pre.xml EX-101.PRE 434340
98 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_063024_htm.xml XML 1368904
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 241217624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)